In agreement with our in vitro data, GIPA-2 acutely blocked the endogenous GIP incretin effect, impaired glucose tolerance, and inhibited the improved glucose tolerance elicited by exogenously administered native GIP. This evidence concerns the gene GIP and Impaired glucose tolerance.